Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
hepatitis B
Biotech
Vir won't advance potential hep B 'cure' without a partner
Vir may be pushing ahead with its combination therapy in hepatitis D, but it's pausing development in hepatitis B while it seeks a suitable partner.
James Waldron
Feb 27, 2025 11:37am
VC firm fights to end Dynavax's 'empire-building' strategy
Feb 19, 2025 2:22pm
2 biotechs shed staff, fuse to form genetic medicine company
Dec 11, 2024 7:00am
GSK axes hepatitis B vaccine trial after missing efficacy goal
Dec 4, 2024 5:15am
Roche culls cough candidate, pivots KRAS program in Q3 update
Oct 23, 2024 6:35am
Barinthus lays off 25%, sidelines prostate cancer program
Jun 13, 2024 5:30am
